Evidence map›Paper›PMID 23027172›Full record

ArticlePediatrics2012

Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.

Sara K Pasquali, Wendy K Lam, Karen Chiswell, Alex R Kemper, Jennifer S Li

Abstract read
In one paragraph

Article in Pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Journal of child health care : for professionals working with children in the hospital and community · 2022
    Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Open forum infectious diseases · 2023
    Article
  17. A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials.World journal of otorhinolaryngology - head and neck surgery · 2023
    Article
  18. Article
  19. Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): A pilot randomized trial.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara K PasqualiDepartment of Pediatrics, Duke University School of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA. pasquali@med.umich.edu
Wendy K Lam
Karen Chiswell
Alex R Kemper
Jennifer S Li

Funding

Pilot Project for the DTMI CRA ProgramUL1RR024128 · NCRR · DUKE UNIVERSITY · PI CALIFF, ROBERT M · 2006 to 2010
$48.1M
Clinical Trials Transformation InitiativeU19FD003800 · FDA · DUKE UNIVERSITY · PI CALIFF, ROBERT · 2009 to 2013
$8.5M
Duke CTSAUL1TR000436 · NCATS · DUKE UNIVERSITY · PI CALIFF, ROBERT M · 2012 to 2012
$2.0M
Career Development in Outcomes Assessment in Congenital Heart SurgeryK08HL103631 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PASQUALI, SARA · 2010 to 2014
$502k
FDA HHS U19 FD003800NCATS NIH HHS UL1 TR000436NCRR NIH HHS UL1 RR024128NHLBI NIH HHS 1K08HL103631-01NHLBI NIH HHS K08 HL103631
6 · The paper itself

Abstract

BACKGROUND AND

objectivesClinical trials are the gold standard for generating evidence-based knowledge in medicine. Recent legislation requiring trials to be registered at ClinicalTrials.gov has enabled evaluation of the clinical trial enterprise as a whole, which was previously not possible. The purpose of this study was to create a snapshot of the pediatric clinical trial portfolio.

methodsAll interventional trials registered at ClinicalTrials.gov from July 2005 to September 2010 were included. Pediatric (ie, enrolling patients aged 0-18 years) trial characteristics, therapeutic area, location, and funding were described. Secondary objectives included describing pediatric trials over time and comparison with nonpediatric trials.

resultsDuring this time, 5035 pediatric trials were registered compared with >10 times as many nonpediatric trials. Neonates/infants were eligible for enrollment in 46.6% of trials versus children (77.9%) and adolescents (45.2%). Nearly one-half of pediatric trials enrolled <100 subjects, and more pediatric trials versus nonpediatric trials evaluated preventive therapies. The proportion of pediatric trials evaluating a drug intervention declined over time, and there were fewer Phase 0 to II versus Phase III to IV trials. Infectious disease/vaccine studies (23%) were the most common, followed by psychiatric/mental health (13%) studies. Many trials enrolled patients outside the United States, and <15% of trials were sponsored by the National Institutes of Health or other US federal agencies.

conclusionsAnalysis of the ClinicalTrials.gov data set allows description of the current scope of pediatric trials. These data may be useful to stakeholders in informing decisions regarding the conduct of trials in children and provide insight into mechanisms to advance pediatric trial infrastructure and methodology toward improving child health.

Indexed as

Clinical Trials as TopicPediatricsRegistriesAdolescentChildChild, PreschoolHumansInfantInfant, NewbornUnited States

Identifiers

PMID23027172
PMCPMC4074644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.